US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
カナダ
TSXV
Total Metals Corp (TT) 銘柄情報

Total Metals Corp (TT)

0.24

-0.02

( -7.69% )

更新日時： 01:30:04

Total Metals Corp (TT) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.24

( -7.69% )

買値

0.24

売値

0.255

出来高

60,720

0.24 日の範囲 0.255

0.00 52 週間の範囲 0.00

時価総額

前日終値

0.26

始値

0.255

時刻

最終取引時間

01:30:04

財務取引量

-

VWAP

-

平均取引量 (3 か月)

$ 174,531

発行済株式数

59,315,766

配当利回り

PER

-2.8

1 株当たり利益 (EPS)

-0.09

歳入

-

純利益

-2.85M

Total Metals Corp. engages in the acquisition, exploration, and development of mineral properties in North America. The company holds interest in the Electrolode property comprises 160 mining claims covering approximately 3,346 hectares located in the Red Lake Mining District of Northern Ontario. It... Total Metals Corp. engages in the acquisition, exploration, and development of mineral properties in North America. The company holds interest in the Electrolode property comprises 160 mining claims covering approximately 3,346 hectares located in the Red Lake Mining District of Northern Ontario. It also holds 100% interests in High Lake and West Hawk Lake Project located in west of Kenora, Ontario; Menary Gold Project that consists of 27 mining claims and 1 mining lease comprising an area of 276.5 hectares and is located in the Kenora Mining Division of Ontario; and Pick Lake Critical Minerals Property consisting of 75 claims and a mining lease covering over 5,260 hectares and is located in Winston Lake greenstone belt. The company is based in Vancouver, Canada. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.totalmetalscorp.com

本社

Vancouver, Canada

設立

-

Total Metals Corp is listed in the sector of the トロントベンチャー取引所 with ticker TT. The last closing price for Total Metals was $0.26. Over the last year, Total Metals shares have traded in a share price range of $ 0.00 to $ 0.00.

Total Metals currently has 59,315,766 shares in issue. The market capitalisation of Total Metals is $14.24 million. Total Metals has a price to earnings ratio (PE ratio) of -2.80.

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - TT

L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - TT Canada NewsWire VANCOUVER, BC...

Canadian Investment Regulatory Organization Trade Resumption - TT

Canadian Investment Regulatory Organization Trade Resumption - TT Canada NewsWire VANCOUVER, BC, Sept. 24, 2025 VANCOUVER, BC, Sept. 24, 2025...

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - TT

Suspension de la négociation par l'Organisme canadien de réglementation des investissements - TT Canada NewsWire VANCOUVER, BC, le...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

TT - Frequently Asked Questions (FAQ)

What is the current Total Metals Corp share price?

The current share price of Total Metals Corp is $ 0.24

How many Total Metals Corp shares are in issue?

Total Metals Corp has 59,315,766 shares in issue

What is the market cap of Total Metals Corp?

The market capitalisation of Total Metals Corp is CAD 14.24M

What is the 1 year trading range for Total Metals Corp share price?

Total Metals Corp has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of Total Metals Corp?

The price to earnings ratio of Total Metals Corp is -2.8

What is the registered address of Total Metals Corp?

The registered address for Total Metals Corp is 700 - 838 W Hastings Street, Vancouver, British Columbia, V6C 0A6

What is the Total Metals Corp website address?

The website address for Total Metals Corp is www.totalmetalscorp.com

williamssc

williamssc 3分前

Slide16 “Overall Conclusions: The survival benefit associated with DCVax-L treatment reflects a true treatment affect and was underestimated in the original analysis”

NASDAQ2020

NASDAQ2020 4分前

i will wait for Monday to grab some more ??

GoodGuyBill

GoodGuyBill 5分前

Brazen22, you’re trying to reduce three years of regulatory progress to one sentence: “You don’t have an approved MAA.”

Of course we don’t — yet. Approval is the destination. We have a validated MAA. What matters is whether NWBO has completed the steps that regulators require before a

NASDAQ2020

NASDAQ2020 5分前

THATS WHEN i ACCUMULATE. At The hammerbottom.

nowwhat2

nowwhat2 5分前

https://investorshub.advfn.com/uimage/uploads/2026/7/3/vwgethg_july_3_2y_plunge_sell.jpg

rizona

Slides! JAMA study UNDERESTIMATED survival benefit

https://nwbio.com/wp-content/uploads/NWBT-BNOS-slides-7-3-26MB-LP-final.pdf

rosemountbomber

rosemountbomber 8分前

I agree with your thinking and also what needs to be considered is after decimating the board, just a desire to be acquired doesn’t automatically make that happen. Some other party has to be interested in acquiring Amarin. What happens then if no one steps up?

chereb19

chereb19 8分前

This is another post built on false equivalence. Sharing Y-90 doesn't make two products the same any more than sharing aspirin makes every painkiller identical.

You keep calling them competitors while ignoring they're fundamentally different technologies. One is a hydrogel platform, t

NASDAQ2020

NASDAQ2020 10分前

Im glad I held my shares past $0.15

Idunno

Idunno 10分前

And don’t forget your buddy, AF. … .. .

Doc logic

Doc logic 10分前

HappyLibrarian,

You are mistakenly overstating my claim which is a common problem so no harm no foul. Manufacturing transition preparedness is what I am suggesting must be in place. Artisan will be utilized to start as NWBO has consistently stated and the MIA is based on that model.

rcaselli

rcaselli 10分前

Just knowing JCTB1 is here is good enuf for me, okay.
See ya all topside….
$LBRG

Idunno

Idunno 11分前

Have at it Brazen! ;) … .. . :)

CatfishHunter

CatfishHunter 13分前

Every biotech founder believes their design choice was the right one — that’s true of BetaGlue’s surgeon-founder and it was true of Fisher/Korenko too. Design rationale explains intent, not outcome. The question that matters is what the trial data shows for each product, not why either team picked t

asp42001

asp42001 13分前

Digital USIO & AI Payment Potential:

(USIO In-Part):

"Embedded payments are the hidden engine under the hood of the apps and platforms we use every day. When you buy a ticket through a sports app or pay for a round of golf lessons online, embedded payments are doing the

BigBadWolf

BigBadWolf 13分前

$Ownership😘 of @ this point w/ irrefutable DD
🤔https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177573771&txt2find=reactor

mgland

mgland 15分前

https://x.com/thommic/status/2072760144774005081

GTF

Just so you know the clock on the 12 month restricted period for SNTX divvy shares began on June 17th, 2026. It doesn't matter that the deliverance of shares to the gtvh shareholders is taking some time. The clock begins when SNTX creates and issues the shares...meaning the day OTCmarkets shows the

manibiotech

manibiotech 17分前

I like this line in couple of PSM analysis slides:

“ Conclusion: Based on these more precisely matched comparisons,
the survival benefit with DCVax-L was likely underestimated
in the original analysis”

Very encouraging . Now let’s see when MHRA does its jo

ErnieBilco

ErnieBilco 18分前

Good to know because I was thinking about letting it go but now I have a reason to hold

gdog

This is by far the Best piece Gary has written imho

https://garywallach.substack.com/p/from-qualification-to-harvest-could?r=3iu9hl&utm_campaign=post&utm_medium=web&triedRedirect=true

AngeloFoca

AngeloFoca 19分前

I doubt you will agree or bother reading what I have said but at least it wasn’t written by some AI.
I have read it all and you are right... I don't agree with ANY of it.

No, I don't believe they have done EVERYTHING right... But I do believe that had it been any other CEO...

rmoss

Stay away stay very far away........

flipper44

flipper44 21分前

I’m busy today, but these results are in line with what I expected. Excellent, and very helpful for all current and potential stakeholders. Great for patients! For current therapy as well as future improvements with combination therapy. Happy 4th Tomorrow! (Top notch for valuation)

stoxjock

stoxjock 21分前

Ok, This Explains it. I didn't know which Wall St (Or elsewhere in Europe like James St) Scoundrel "Creditors' were "Filing TWICE or even More' to get their Money from multiple Lehman Entities ..Frankly, those SCUM should be prosecuted for Fraud and Thrown in Jail for Good...

Investigator Silver

New Zealand Coastal Seaf...

National RMBS Trust 2015...

Macallum New Energy

Scottish Salmon

Buddy Technologies

DIIV27N29 - 10/2027

Greenwich Agro Fi Cad Pr...

Rafaella Resources

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。